Gediminas Urbonas

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Long‐term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)—results from the European phase 3 open‐label safety trial

Jan Tack, Juris Pokrotnieks, Gediminas Urbonas et al. · Neurogastroenterology & Motility · 2018 · 51 citations · Full text

Pain Disorders, Pain Medicine, Pharmacotherapy +21

The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting

Gediminas Urbonas, Leonas Valius, Gintarė Šakalytė et al. · Medicina · 2019 · 32 citations · Full text

Assessing the Pilot Implementation of the Integrated Multimorbidity Care Model in Five European Settings: Results from the Joint Action CHRODIS-PLUS

Carmen Rodríguez‐Blázquez, Maria João Forjaz, Antonio Gimeno‐Miguel et al. · International Journal of Environmental Research and Public Health · 2020 · 16 citations · Full text